
Vitrolife AB: directors' dealings · Finland · FIN-FSA
FI:vitrolife-abSE0011205202FIFI·FIN-FSAMcap 14.1Bn€Healthcare
Explore the full insider trade history of Vitrolife AB, a listed issuer based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Vitrolife AB has recorded 3 insider filings. Market capitalisation: €14.1bn. The latest transaction was filed on 6 February 2026 — Purchase. Among the most active insiders: Bronwyn Brophy O'Connor. Every trade is openly available.
Financial data
FY ended December 2025 · cache
Analyst consensus
4 analysts131.00 €Target 162.75 €(+56%)215.00 €
Income statement
Revenue3.44 Bn€
Gross profit2.00 Bn€58% margin
Net income−5.01 Bn€-147.2% margin
Valuation
PER (forward)18.2x
P/Book1.8x
Beta1.73
Balance sheet & cash
Market cap14.13 Bn€
Total debt1.60 Bn€
Free Cash Flow388.0 M€
Debt / Equity20%
Profitability & ownership
ROE-47.3%
ROA2.6%
% insiders29.7%
% institutions55.7%
Last declaration on 6 February 2026